Publications by authors named "Douglas Rank"

Claim this Profile
E
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
John E Mazuski, Leanne B Gasink, Jon Armstrong, Helen Broadhurst, Greg G Stone, Douglas Rank

Clin Infect Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.
Todd A Riccobene, Ludmyla Rekeda, Douglas Rank, Lily Llorens

Antimicrob Agents Chemother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects.
Todd A Riccobene, Sheng Fang Su, Douglas Rank

Antimicrob Agents Chemother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
H David Friedland, Tanya O'Neal, Donald Biek, Paul B Eckburg, Douglas R Rank

Antimicrob Agents Chemother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia.
Douglas R Rank, H David Friedland, Joseph B Laudano

J Antimicrob Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo.
Daniel T Dransfield, Edward H Cohen, Qing Chang, Lindsay G Sparrow, John D Bentley, Douglas Rank

Mol Cancer Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning of Salmonella enterica serovar Enteritidis fimbrial protein SefA as a surface protein in Escherichia coli confers the ability to attach to eukaryotic cell lines.
Douglas L Rank, Mahdi A Saeed, Peter M Muriana

Appl Environ Microbiol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.
Laetitia Devy, Lili Huang, Laurent Naa, Niranjan Yanamandra, Henk Pieters, Douglas Rank

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: a case study.
Marie M Zhu, Asti Goyal, Douglas L Rank, Sunil K Gupta, Thomas Vanden Boom

Biotechnol Prog· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis